retatrutide approval is one of the most exciting medications currently being studied for obesity and metabolic disease-but there's one important thing to understand: It is NOT approved yet. I get asked almost daily, “ ⚠️ “RETA” is NOT an

Combining them might intensify these uncomfortable GI symptoms, making it harder to stay consistent with your program

Moving forward with healthy weight management With dedication, provider support, and a supportive community, it is possible to meet and sustain your ideal weight

Mazdutide is an engineered oxyntomodulin analog with modifications (including fatty acid acylation) that extend its half-life to approximately 56 days, enabling once-weekly dosing while retaining the dual receptor agonism of the natural hormone

The decision to move from tirzepatide to retatrutide usually comes from one of several frustrations, and understanding your specific motivation matters because it shapes how you approach the transition

Together, this dual strategy may reduce the energetic bottleneck that characterizes early neurodegenerative states

Weight reduction has many positive effects, from improving insulin sensitivity to reducing the risk of cardiovascular diseases (40, 56, 57)